iSpecimen Inc. Files 8-K Report

Ticker: ISPC · Form: 8-K · Filed: Mar 14, 2024 · CIK: 1558569

Sentiment: neutral

Topics: financial-reporting, 8-K

TL;DR

iSpecimen filed an 8-K on March 14, 2024, with financial updates.

AI Summary

On March 14, 2024, iSpecimen Inc. filed an 8-K report detailing its financial condition and operations. The filing includes financial statements and exhibits, but does not specify any new material events or significant financial changes.

Why It Matters

This filing provides an update on iSpecimen Inc.'s financial condition and operations, which is important for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report and does not indicate any immediate or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for iSpecimen Inc.?

The primary purpose is to report on the Results of Operations and Financial Condition, Regulation FD Disclosure, and Financial Statements and Exhibits as of March 14, 2024.

What is the exact name of the registrant?

The exact name of the registrant is iSpecimen Inc.

In which state was iSpecimen Inc. incorporated?

iSpecimen Inc. was incorporated in Delaware.

What is the principal executive office address for iSpecimen Inc.?

The principal executive office address is 450 Bedford Street, Suite 1010, Lexington, MA 02420.

What is the telephone number for iSpecimen Inc.?

The telephone number for iSpecimen Inc. is (781) 301-6700.

Filing Stats: 1,380 words · 6 min read · ~5 pages · Grade level 11.6 · Accepted 2024-03-14 09:06:10

Key Financial Figures

Filing Documents

02

Item 2.02. Results of Operations and Financial Condition. On March 14, 2024, iSpecimen Inc., a Delaware corporation (the " Company "), issued a press release (" Earnings Release ") announcing its financial and operating results for the fiscal year ended December 31, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The Company also filed its audited financial statements for the fiscal year ended December 31, 2023 with its Annual Report on Form 10-K on March 13, 2024. The Earnings Release contains certain statements and information that speak to the Company's expectations or predictions of the future. These statements and information may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the " Securities Act "), and Section 21E of the Securities Exchange Act of 1934, as amended (the " Exchange Act "). Such forward-looking statements are subject to risks and uncertainties, many of which are beyond the Company's control, which could cause the Company's actual results to differ materially from those expressed in or implied by these statements. Please see the Company's disclosures regarding risk factors and forward-looking statements in its filings with the Securities and Exchange Commission (the "SEC") (including its Current Reports on Form 8-K, Quarterly Reports on Form 10-Q, and Annual Report on Form 10-K) for a discussion of the known material factors that could cause the Company's actual results to differ materially from those indicated or implied by such forward-looking The information in this Item 2.02 and Exhibit 99.1 attached hereto will not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor will it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing

01

Item 7.01. Regulation FD Disclosure. The Company also held a conference call and audio webcast at 8:30 a.m. Eastern Time on March 14, 2024 (" Earnings Call ") in which it discussed its fiscal year 2023 results. The Company issued a press release on March 5, 2024, providing information on how to access the Earnings Call. A replay of the Earnings Call is available through March 27, 2024, by calling +1-844-512-2921 (U.S. toll free) or +1-412-317-6671 (for international callers). An archived version of the Earnings Call will also be available on the Company's Investor Relations site at https://investors.ispecimen.com/presentations/ . During the Earnings Call, the Company provided an investor presentation, dated March 2024 (the " Presentation "), which is attached hereto as Exhibit 99.2 and incorporated by reference herein. The Presentation will also be posted on the Company's website and can be accessed at https://investors.ispecimen.com/ . The Company expressly disclaims any obligation to update the Presentation, or any other information posted on or available through its website, and cautions that the information set forth therein is only accurate as of the date indicated on such materials. The inclusion of any data or statements in the Presentation (or available on or through the Company's website) does not signify that such information is considered material. The information in this Item 7.01 and Exhibit 99.2 attached hereto will not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor will it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K may contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Such forward-looking statements are characterized by future or conditional verbs such as "may," "will," "expect," "intend," "anticipate," "believe," "estimate" and "continue" or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. Such statements are only predictions and the Company's actual results may differ materially from those anticipated in these forward-looking statements. There may be events in the future that the Company is not able to accurately predict or control. Factors that may cause such differences include, but are not limited to, those discussed under risk factors in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and other filings filed with the SEC, including the uncertainties associated with the Company's lack of profitability, its continued capital needs, its lack of a long operating history, its growth strategy, inflation and recession and its impact on the business, Russia's war with Ukraine and its impact on the operations, its technology development plans, and the regulatory environment in which it operates. Forward-looking statements speak only as of the date they are made. The Company does not assume any obligation to update forward-looking You may access the Company's SEC filings by visiting SEC's website at http://www.sec.gov . This Current Report on Form 8-K does not constitute an offer or invitation for the sale or purchase of securities or to engage in any other transaction with the Company or its affiliates. The

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. 99.1 Press Release, dated March 14, 2024. 99.2 Investor Presentation, dated March 2024. 104 Cover Page Interactive Data File Portions of this report may constitute "forward-looking is no assurance that actual outcomes will not be materially different. Additional information about issues that could lead to material changes in the Company's performance is contained in the Company's filings with the SEC. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: March 14, 2024 iSPECIMEN INC. By: /s/ Tracy Curley Name: Tracy Curley Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing